Financial Strategies Acquisition Corp. (FXCO) to Combine with Austin Biosciences in $166M Deal

Financial Strategies (NASDAQ:FXCO) has entered into a definitive agreement to combine with pharmaceutical company Austin Biosciences Corp with a post-deal market capitalization of $166.3 million. The Austin, Minnesota-based company is developing preclinical drug candidates that could potentially improve upon existing cancer treatments. The combined company is expected to trade on the Nasdaq under the symbol
Read More